Will Praxbind Reign as a Safe Antidote to Pradaxa?
October 23, 2015
Although there is still no antidote for Xarelto or Eliquis, the European Medicines Agency (EMA) is fast-tracking Praxbind as an antidote for the blood thinner Pradaxa. Pradaxa patients have been injured and dying due to the anticoagulant causing uncontrollable bleeding in emergencies. The life-threatening risk of uncontrolled bleeding is a constant threat to Pradaxa patients. The Committee for Medicinial Products for Human Use (CHMP) recommended marketing authorization after its rapid assessment of Praxbind. The study resulted in reveral of Pradaxa’s anticoagulant effect 5 minutes after the patients in the Praxbind drug study took the antidote.
Fears Nachawati’s Pradaxa attorneys are studying, examining and investigating Pradaxa claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Pradaxa, contact our Pradaxa lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at firstname.lastname@example.org